SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael Morrissey, Ph.D., the company’s president and chief executive officer, will present at the Lazard Capital Markets 8th Annual Healthcare Conference at 10:00 a.m. EST / 7:00 a.m. PST on Tuesday, November 15, 2011, in New York. Dr. Morrissey will provide a general business update, review the most recent publicly available data for cabozantinib, and discuss the pivotal trial plans and regulatory strategy for the compound.
